New nanodevice to improve cancer treatment monitoring
2014-10-27
(Press-News.org) This news release is available in French.
In less than a minute, a miniature device developed at the University of Montreal can measure a patient's blood for methotrexate, a commonly used but potentially toxic cancer drug. Just as accurate and ten times less expensive than equipment currently used in hospitals, this nanoscale device has an optical system that can rapidly gauge the optimal dose of methotrexate a patient needs, while minimizing the drug's adverse effects. The research was led by Jean-François Masson and Joelle Pelletier of the university's Department of Chemistry.
Methotrexate has been used for many years to treat certain cancers, among other diseases, because of its ability to block the enzyme dihydrofolate reductase (DHFR). This enzyme is active in the synthesis of DNA precursors and thus promotes the proliferation of cancer cells. "While effective, methotrexate is also highly toxic and can damage the healthy cells of patients, hence the importance of closely monitoring the drug's concentration in the serum of treated individuals to adjust the dosage," Masson explained.
Until now, monitoring has been done in hospitals with a device using fluorescent bioassays to measure light polarization produced by a drug sample. "The operation of the current device is based on a cumbersome, expensive platform that requires experienced personnel because of the many samples that need to be manipulated," Masson said.
Six years ago, Joelle Pelletier, a specialist of the DHFR enzyme, and Jean-François Masson, an expert in biomedical instrument design, investigated how to simplify the measurement of methotrexate concentration in patients.
Gold nanoparticles on the surface of the receptacle change the colour of the light detected by the instrument. The detected colour reflects the exact concentration of the drug in the blood sample. In the course of their research, they developed and manufactured a miniaturized device that works by surface plasmon resonance. Roughly, it measures the concentration of serum (or blood) methotrexate through gold nanoparticles on the surface of a receptacle. In "competing" with methotrexate to block the enzyme, the gold nanoparticles change the colour of the light detected by the instrument. And the colour of the light detected reflects the exact concentration of the drug in the blood sample.
The accuracy of the measurements taken by the new device were compared with those produced by equipment used at the Maisonneuve-Rosemont Hospital in Montreal. "Testing was conclusive: not only were the measurements as accurate, but our device took less than 60 seconds to produce results, compared to 30 minutes for current devices," Masson said. Moreover, the comparative tests were performed by laboratory technicians who were not experienced with surface plasmon resonance and did not encounter major difficulties in operating the new equipment or obtaining the same conclusive results as Masson and his research team.
In addition to producing results in real time, the device designed by Masson is small and portable and requires little manipulation of samples. "In the near future, we can foresee the device in doctors' offices or even at the bedside, where patients would receive individualized and optimal doses while minimizing the risk of complications," Masson said. Another benefit, and a considerable one: "While traditional equipment requires an investment of around $100,000, the new mobile device would likely cost ten times less, around $10,000."
INFORMATION:
About this study:
This research received funding from the National Science and Engineering Research Council (NSERC) of Canada, the Centre for self-assembled chemical structures (CSACS), Fonds québécois de recherche – Nature et technologies (FRQ-NT) and Institut Mérieux.
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2014-10-26
In an analysis that included approximately 35,000 participants, genetic predisposition to elevated low-density lipoprotein cholesterol (LDL-C) was associated with aortic valve calcium and narrowing of the aortic valve, findings that support a causal association between LDL-C and aortic valve disease, according to a study appearing in JAMA. The study is being released to coincide with its presentation at the Canadian Cardiovascular Congress.
Aortic valve disease remains the most common form of heart valve disease in Europe and North America and is the most common indication ...
2014-10-26
Stanford, CA— Proteins are the machinery that accomplishes almost every task in every cell in every living organism. The instructions for how to build each protein are written into a cell's DNA. But once the proteins are constructed, they must be shipped off to the proper place to perform their jobs. New work from a team of scientists led by Carnegie's Munevver Aksoy and Arthur Grossman, describes a potentially new pathway for targeting newly manufactured proteins to the correct location. Their work is published by The Plant Cell.
The team's discovery concerns ...
2014-10-26
October 26, 2014, New York, NY – Ludwig Oxford researchers have discovered a key mechanism that governs how cells of the epithelia, the soft lining of inner body cavities, shift between a rigid, highly structured and immobile state and a flexible and motile form. Published in the current issue of Nature Cell Biology, their study shows that a tumor suppressor protein named ASPP2 functions as a molecular switch that controls this process and its reverse, both of which play a critical role in a number of biological phenomena, including wound healing, embryonic development ...
2014-10-26
PROVIDENCE, R.I. [Brown University] — Superconductors and magnetic fields do not usually get along. But a research team led by a Brown University physicist has produced new evidence for an exotic superconducting state, first predicted a half-century ago, that can indeed arise when a superconductor is exposed to a strong magnetic field.
"It took 50 years to show that this phenomenon indeed happens," said Vesna Mitrovic, associate professor of physics at Brown University, who led the work. "We have identified the microscopic nature of this exotic quantum state of ...
2014-10-26
Scientists have created cells with fluorescent dyes that change color in response to specific neurochemicals. By implanting these cells into living mammalian brains, they have shown how neurochemical signaling changes as a food reward drives learning, they report in Nature Methods online October 26.
These cells, called CNiFERs (pronounced "sniffers"), can detect small amounts of a neurotransmitter, either dopamine or norepinephrine, with fine resolution in both location and timing. Dopamine has long been of interest to neuroscientists for its role in learning, reward, ...
2014-10-26
Lasers – devices that deliver beams of highly organized light – are so deeply integrated into modern technology that their basic operations would seem well understood. CD players, medical diagnostics and military surveillance all depend on lasers.
Re-examining longstanding beliefs about the physics of these devices, Princeton engineers have now shown that carefully restricting the delivery of power to certain areas within a laser could boost its output by many orders of magnitude. The finding, published Oct. 26 in the journal Nature Photonics, could allow ...
2014-10-26
NEW YORK, NY (October 26, 2014)—Dietary cocoa flavanols—naturally occurring bioactives found in cocoa—reversed age-related memory decline in healthy older adults, according to a study led by Columbia University Medical Center (CUMC) scientists. The study, published today in the advance online issue of Nature Neuroscience, provides the first direct evidence that one component of age-related memory decline in humans is caused by changes in a specific region of the brain and that this form of memory decline can be improved by a dietary intervention.
As ...
2014-10-26
MOUNT WILSON, Calif.–Astronomers at Georgia State University's Center for High Angular Resolution Astronomy (CHARA) have observed the expanding thermonuclear fireball from a nova that erupted last year in the constellation Delphinus with unprecedented clarity.
The observations produced the first images of a nova during the early fireball stage and revealed how the structure of the ejected material evolves as the gas expands and cools. It appears the expansion is more complicated than simple models previously predicted, scientists said. The results of these observations, ...
2014-10-26
BOSTON –– Scientists say they have identified in about 20 percent of colorectal and endometrial cancers a genetic mutation that had been overlooked in recent large, comprehensive gene searches. With this discovery, the altered gene, called RNF43, now ranks as one of the most common mutations in the two cancer types.
Reporting in the October 26, 2014 edition of Nature Genetics, investigators from Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard said the mutated gene helps control an important cell-signaling pathway, Wnt, that has been ...
2014-10-26
Why do we remember some things and not others? In a unique imaging study, two Northwestern University researchers have discovered how neurons in the brain might allow some experiences to be remembered while others are forgotten. It turns out, if you want to remember something about your environment, you better involve your dendrites.
Using a high-resolution, one-of-a-kind microscope, Daniel A. Dombeck and Mark E. J. Sheffield peered into the brain of a living animal and saw exactly what was happening in individual neurons called place cells as the animal navigated a virtual ...
LAST 30 PRESS RELEASES:
[Press-News.org] New nanodevice to improve cancer treatment monitoring
